Suppr超能文献

药物稳定性研究的精密度。高效液相色谱分析方法可靠重复性和中间精密度的考察。

Precision from drug stability studies. Investigation of reliable repeatability and intermediate precision of HPLC assay procedures.

作者信息

Ermer Joachim, Arth Christoph, De Raeve Phillippe, Dill Donald, Friedel Horst-Dieter, Höwer-Fritzen Heidi, Kleinschmidt Gerd, Köller Gerhard, Köppel Heidi, Kramer Mathias, Maegerlein Markus, Schepers Udo, Wätzig Hermann

机构信息

Department of Industrial Quality and Compliance, Sanofi-Aventis, Industriepark Höchst, Geb. H831 D-65926, Frankfurt am Main, Germany.

出版信息

J Pharm Biomed Anal. 2005 Jul 15;38(4):653-63. doi: 10.1016/j.jpba.2005.02.009. Epub 2005 Apr 12.

Abstract

A multi-company investigation is presented to obtain and compare precision results for LC assay procedures. Forty-four drug substances and drug products of various types subjected to 156 stability studies, with 2915 assay values in total, were included. This provides an excellent source of real long-term precision estimates, as the same analytical procedure was applied during the whole stability study, extending from 12 to 60 months. Intermediate precision was calculated either using the residual standard deviation of the regression line or applying an analysis of variances, depending on whether there was a significant degradation of the analyte or not. The results show impressively the large intervals where the individually calculated parameters scatter. Distribution ranges and averages for repeatability, intermediate precision, and the ratio between the two precision levels are mainly dependent on the type of drug product. Repeatabilities were found up to 0.8% for solutions, 1.6% for drug substances, 1.9% for tablets, 2.3% for creams, and 3.4% for a bath. For intermediate precision, which includes additional variability factors due to the reference standard, operator, equipment, reagents, etc., a similar dependency was obtained with a slightly changed order: up to 1.1% for drug substances, 2.2% for solutions, 2.3% for tablets, 3.1% for creams, and 3.2% for a bath. The ratio between the precision levels is up to 2.5 and similar for all investigated drug product types, apart from solutions with up to 5.3. These differences for the types of drug product may be explained by the influence of the sample and/or the sample preparation: the more complex, the higher the variability contribution. For the investigated examples, the impact of the analyte and of the concentration (dosage) seems to be of less importance. Therefore, a classification of drug product types for orientation on acceptable precision (ranges) for LC assay seems to be possible.

摘要

本文介绍了一项多公司联合调查,旨在获取并比较液相色谱(LC)分析方法的精密度结果。研究纳入了44种不同类型的药物原料和药品,共进行了156项稳定性研究,总计获得2915个分析值。这为实际长期精密度评估提供了绝佳的数据来源,因为在整个长达12至60个月的稳定性研究过程中,采用的是相同的分析方法。根据分析物是否存在显著降解,分别使用回归线的剩余标准差或方差分析来计算中间精密度。结果令人印象深刻地显示了各个计算参数的分散区间之大。重复性、中间精密度以及两种精密度水平之比的分布范围和平均值主要取决于药品类型。溶液的重复性高达0.8%,药物原料为1.6%,片剂为1.9%,乳膏为2.3%,浴液为3.4%。对于包含因参考标准、操作人员、设备、试剂等导致的额外变异性因素的中间精密度,也获得了类似的相关性,只是顺序略有变化:药物原料高达1.1%,溶液为2.2%,片剂为2.3%,乳膏为3.1%,浴液为3.2%。除溶液高达5.3外,所有研究的药品类型的精密度水平之比高达2.5且相似。药品类型的这些差异可能是由样品和/或样品制备的影响所解释:越复杂,变异性贡献越高。对于所研究的示例,分析物和浓度(剂量)的影响似乎不太重要。因此,对药品类型进行分类,以便为LC分析的可接受精密度(范围)提供指导似乎是可行的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验